Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  General Pharmaceutical

Carrington Laboratories Inc-Therapeutic Competitors


Published Date: July 2008
Published By: Life Science Analytics (LSA)
Page Count: 28
Order Code: R762-22811
 
DescriptionTable of ContentsSimilar
Products

Carrington Laboratories Inc-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Scope of the reports
  • Life Science Analytics’ Competitor Reports deliver detailed analysis of a company’s preclinical, clinical and marketed pipeline of products.
  • A complete listing of each company’s entire pipeline is provided along with graphical and tabular presentation of the pipeline by therapeutic or disease category.
  • Every Competitor Report lists a company’s individual marketed and pipeline products by disease area, as well as detail on public and private company competitors for each.
An overview of each company’s discontinued product line provides insight into product attrition rates.

Life Science Analytics’ Competitor Reports provide extensive information including:
  • Company business descriptions
  • Product pipelines by stage of development including discontinued products
  • Therapeutic areas of research
  • Indications treated
  • An extensive list of competitors by disease indication.
Key benefits

Competitor Reports provide the user with independent insight into a company’s management structure, financial position and products - vital intelligence for investors, competitors and partners.

Understand the uniqueness of a company’s pipeline by obtaining detail on competitive products in development by other public and private companies - independent information that will enable the user to make informed strategic decisions.

Graphical representation of data coupled with detailed listings of all products in development and in production allows the user to quickly assess the depth of a company’s pipeline and the strength of the company’s product portfolio.

Similar Products
Pharmaceutical Alliance Management
Published Jan 2009 by Cutting Edge Information


Diabetes Market Forecast to 2013
Published Jan 2009 by Cutting Edge Information


Kenya Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Kuwait Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


France Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Bangladesh Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Study for Opportunities Assessment for Hepatitis B Therapeutics in Korea
Published Dec 2008 by Frost & Sullivan


Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Published Dec 2008 by Frost & Sullivan


Study for Opportunities Assessment for Hepatitis B Therapeutics in India
Published Dec 2008 by Frost & Sullivan


India Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com